You Searched For "SII" and got 20 results
Sort By:
Zoho to Zerodha, here are the 10 most valuable bootstrapped companies in India
In a world dominated by venture capital and large-scale investments, a select group of Indian compa…
Should you be worried about the potential side-effects of the Covishield vaccine?
Thrombosis with Thrombocytopenia Syndrome (TTS), can lead to dangerously low blood clot and platele…
Serum Institute's Covovax gets DCGI approval as a heterologous booster dose
"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommende…
PTI
Serum Institute applies to Indian authorities for full market authorisation of Covishield
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine t…
PTI
Serum Institute of India seeks permission from DCGI to manufacture 'Sputnik V' COVID-19 vaccine in the country
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories. …
PTI
Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice
"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…
India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates
The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …
SII launches India's first indigenous pneumonia vaccine at $3 per dose
CEO Adar Poonawalla Roughly stated that SII’s pneumococcal conjugate vaccine will cost the gover…
COVID-19 vaccine: SII and Bharat Biotech asked to submit more data for emergency approval
The Central Drugs Standard Control Organisation's Subject Expert Committee on Wednesday asked the S…
Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI
SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…
PTI
Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia
According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…
COVID-19 cases in India cross 32 lakh mark, recovery rate rises to 75.92%
With 67,151 fresh coronavirus infections in 24 hours, India's tally mounted to 32,34,474 on Wednesd…
Oxford COVID-19 vaccine human trials to continue in India, says SII
The testing of Covid-19 vaccine being developed by AstraZeneca and University of Oxford has been pu…
SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations
Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…
After SII's Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel
The authorisation was significant for India as the Pune-based Serum Institute of India had t…
DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis
"... the new coronavirus variant 'omicron' has already been reported in more than 60 countries and…
PTI
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an …
PTI
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
Exports of SII vaccine blocked till March-April
New Delhi, Jan 18 (IANS) Exports of the Oxford-AstraZeneca vaccine by the Serum Institute of India …